Target intelligence / Profile preview

RuvB-like ATPase 2 (RUVBL2)

Target
RUVBL2
Molecular classification
AAA+ ATPase, DNA helicase, Chromatin remodeling complex subunit, Molecular chaperone, Enzyme, Other (involved in multi-subunit nuclear macromolecular assembly complexes)
01

Overview

RuvB-like ATPase 2 (RUVBL2) is a highly conserved AAA+ ATPase and helicase that functions as an essential subunit of several nuclear protein complexes, notably the INO80 and NuA4 chromatin remodeling complexes and the R2TP chaperone. It forms hexameric or dodecameric assemblies, often with its paralog RUVBL1, and is critical for ATP-dependent processes such as DNA unwinding, chromatin remodeling, and transcription regulation. RUVBL2 is a coactivator of RNA polymerase II–dependent transcription and supports the assembly and function of large macromolecular complexes involved in cell cycle progression, DNA repair, and oncogenic transformation[1][2][3][4][5]. RUVBL2 is overexpressed in a variety of cancers, where it regulates oncogene and proto-oncogene function; consequently, it is being investigated as a cancer therapeutic target. Cordycepin has been identified as a small molecule inhibitor of RUVBL2, offering proof of druggability[3]. Given its broad cellular functions and essentiality, therapeutic targeting of RUVBL2 requires careful consideration of potential safety liabilities.

Other names
RuvB-like 2INO80JTIP48TIP49BCGI-4648 kDa TBP-interacting proteinECP-51Reptin 52TAP54-betaRVB2TIP49bReptin52ECP51TIH251 kDa erythrocyte cytosolic proteinINO80 complex subunit JRepressing pontin 52TIP60-associated protein 54-betareptinRvb2
02

Mechanism of action

Inhibition of ATPase activity leading to impaired chromatin remodeling and transcriptional regulation Disruption of multi-protein complex assembly

03

Biological functions

ATP-dependent DNA unwinding (helicase activity)Chromatin remodelingTranscriptional regulation (coactivator)DNA repairCell cycle regulationProtein-protein interaction scaffold
04

Disease associations

Cancer (frequently overexpressed, required for oncogenic transcription programs)Cardiovascular disease (heart hyperplasia)Other (involvement in development/differentiation)
05

Safety considerations

Fundamental cellular roles (cell viability risk with broad inhibition)Potential for toxicity in proliferating tissues due to roles in cell cycle and DNA repair
06

Interacting drugs

Cordycepin (binds and inhibits RUVBL2)
07

Biomarkers

Expression level of RUVBL2 (prognostic in several cancers)

Beyond the preview

Go deeper on RuvB-like ATPase 2 (RUVBL2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RuvB-like ATPase 2 (RUVBL2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call